chines
medicin
herb
extract
screen
antivir
activ
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
use
inner
salt
mt
assay
virusinduc
cytopath
effect
cpe
four
extract
show
moder
potent
antivir
activ
sarscov
effect
concentr
ec
rang
gml
four
lycori
radiata
potent
identifi
activ
compon
l
radiata
extract
subject
fraction
purif
cpemt
assay
process
led
identif
singl
substanc
lycorin
antisarscov
compon
ec
valu
nm
compound
cc
valu
nm
cytotox
assay
select
index
si
greater
result
suggest
four
herbal
extract
compound
lycorin
candid
develop
new
antisarscov
drug
treatment
sar
sever
acut
respiratori
syndrom
sar
respiratori
ill
caus
sever
acut
respiratori
syndrom
coronaviru
sarscov
drosten
et
al
ksiazek
et
al
peiri
et
al
poutanen
et
al
febril
respiratori
ill
initi
describ
earli
chanyeung
yu
donnelli
et
al
lee
et
al
peiri
et
al
tsang
et
al
life
threaten
highli
contagi
current
approv
univers
recommend
therapi
sar
treatment
diseas
mainli
support
scientist
worldwid
vigor
tri
develop
efficaci
antivir
agent
treatment
sar
event
sar
come
back
futur
report
sever
group
cinatl
et
al
b
scagnolari
et
al
suggest
reagent
interferon
glycyrrhizin
pose
antisarscov
activ
china
tradit
herbal
medicin
frequent
use
conjunct
convent
medicin
treat
sar
evid
show
herbal
medicin
effect
lin
et
al
xiao
et
al
zhao
et
al
zhong
zeng
howev
mechan
treatment
clearli
understood
shown
natur
plant
contain
antivir
activ
coronavirus
mccutcheon
et
al
mechan
action
herbal
product
mainli
inhibit
vlietinck
vanden
bergh
jassim
naji
studi
select
inhousemad
extract
medicin
herb
histor
use
treatment
virusinduc
infecti
diseas
china
test
antivir
activ
sarscov
use
high
throughput
screen
approach
screen
base
mt
assay
cori
et
al
khabar
et
al
activ
sampl
screen
subject
structur
activ
relationship
sar
studi
identifi
singl
activ
chemic
substanc
result
studi
potenti
usag
identifi
lead
compound
treatment
sarscovinduc
infecti
diseas
present
search
new
reagent
antisarscov
collect
herb
extract
reflux
ethanol
chloroform
h
extract
solvent
filter
lyophil
redissolv
dimethyl
sulphoxid
dmso
sigma
store
sampl
plate
c
assay
screen
two
strain
sarscov
use
antivir
compound
screen
obtain
laboratori
virolog
academi
militari
medic
scienc
beij
china
virus
propag
vero
cell
c
humidifi
atmospher
co
vero
cell
cultur
dulbecco
modifi
eagl
medium
dmem
invitrogen
contain
heatinactiv
fetal
bovin
serum
fb
hyclon
sodium
bicarbon
gl
glucos
gl
mm
hepe
buffer
virusinduc
cytopath
effect
cpe
determin
mt
method
visual
cellular
morpholog
chang
number
viabl
cell
correl
absorb
nm
mt
assay
approxim
vero
cellswel
seed
onto
corn
tissu
cultur
plate
corn
incorpor
final
volum
l
cultur
h
ten
microlit
compound
plant
extract
concentr
gml
ad
well
duplic
inocul
viru
stock
interferon
alpha
hualida
biotech
compani
proven
show
antivir
activ
sarscov
cinatl
et
al
scagnolari
et
al
use
posit
control
viral
titer
assess
cytopath
effect
cpe
determin
visual
lightphas
microscop
day
postinfect
pi
concentr
achiev
cell
lysi
use
antivir
compound
screen
infect
cell
without
compound
incub
c
co
atmospher
h
l
mtsphenazin
methosulf
pm
promega
ad
well
cell
incub
anoth
h
c
end
l
sd
ad
stop
color
reaction
plate
measur
nm
use
versamax
micropl
reader
molecular
devic
primari
screen
activ
compound
cherri
pick
second
round
test
perform
antivir
effect
pictur
taken
record
cell
morpholog
chang
caus
cpe
inhibit
effect
compound
mt
assay
shown
fig
four
extract
lycori
radiata
artemisia
annua
pyrrosia
lingua
lindera
aggregata
exhibit
signific
inhibit
effect
virusinduc
cpe
sarscov
strain
use
screen
dose
depend
antivir
activ
determin
serial
dilut
compound
percentag
cpe
reduct
calcul
subtract
mean
valu
virusinfect
cell
control
measur
absorb
result
number
divid
measur
absorb
uninfect
cell
control
mean
valu
standard
deviat
sd
taken
result
analysi
inhibit
effect
four
natur
product
sampl
show
dosedepend
pattern
fig
ec
valu
determin
concentr
compound
need
achiev
inhibit
sarscovinduc
cpe
control
valu
cell
without
viral
infect
data
analysi
assay
perform
use
prism
tm
version
softwar
graphpad
softwar
inc
ec
valu
inhibit
gml
respect
much
lower
previous
identifi
compound
cinatl
et
al
check
whether
signific
strain
variat
use
sarscov
strain
test
inhibit
activ
activ
compound
result
quit
similar
two
viral
strain
tabl
viabil
vero
cell
measur
mt
assay
consist
observ
visual
microscop
photo
shown
addit
activ
compound
significantli
block
viral
infect
replic
kept
cell
viabl
state
interferon
alpha
also
show
limit
inhibit
effect
virusinduc
cpe
either
judg
visual
observ
mt
assay
result
consist
previou
report
cinatl
scagnolari
group
inhibit
four
compound
viru
infectionrepl
appar
potent
interferon
alpha
judg
visual
observ
color
absorb
mt
assay
fig
cytotox
test
activ
compound
base
cell
viabil
cell
treat
variou
concentr
compound
determin
mt
method
vero
cell
micropl
incub
serial
dilut
test
compound
dmem
contain
fb
cell
allow
grow
addit
h
measur
cc
valu
determin
concentr
compound
reduc
cell
viabil
control
cell
without
addit
compound
four
activ
compound
l
radiata
annua
p
lingua
l
aggregata
cc
valu
rang
gml
assay
use
vero
cell
tabl
select
index
si
determin
ratio
cc
versu
ec
one
potent
activ
compound
extract
l
radiata
three
other
also
show
good
si
valu
except
l
aggregata
order
examin
compound
toxic
differ
cell
type
test
four
extract
vero
human
cell
line
cc
valu
l
radiata
annua
p
lingua
l
aggregata
determin
concentr
compound
reduc
cell
viabil
control
cell
without
addit
compound
repres
mean
valu
three
independ
experi
unit
cc
valu
shown
tabl
gml
except
interferon
alpha
iuml
b
determin
concentr
compound
need
inhibit
cpe
control
valu
cell
without
viral
infect
repres
mean
valu
three
independ
experi
unit
ec
valu
shown
tabl
gml
except
interferon
alpha
iuml
c
select
index
cc
ec
gml
respect
data
obtain
two
cell
line
similar
tabl
result
suggest
signific
differ
compound
toxic
two
type
cell
line
result
describ
base
assay
screen
herb
extract
mixtur
mani
compound
would
quit
interest
identifi
effect
compon
antivir
activ
one
activ
sampl
show
better
inhibit
effect
antisarscov
screen
l
radiata
extract
chosen
identif
activ
compon
first
isol
total
alkaloid
l
radiata
accord
previou
report
hong
examin
antivir
activ
base
previou
find
major
bioactiv
compon
l
radiata
alkaloid
fraction
takagi
et
al
miyasaka
hiramatsu
cortes
et
al
cpemt
assay
isol
alkaloid
show
potent
inhibitori
activ
sarscov
infect
tabl
separ
total
alkaloid
compound
rphplc
meohh
gradient
use
shimadzu
hplc
system
shimadzu
co
gener
four
fraction
sampl
b
c
four
fraction
collect
reexamin
antisarscov
activ
result
round
test
indic
fraction
b
signific
inhibitori
activ
sar
cov
other
none
fig
visual
observ
also
show
cpe
induc
viru
infect
vero
cell
block
addit
either
alkaloid
sampl
fraction
sampl
b
data
shown
result
suggest
fraction
b
contain
substanc
activ
sarscov
might
search
determin
concentr
compound
need
inhibit
cpe
control
valu
cell
without
viral
infect
valu
repres
mean
sd
three
independ
experi
unit
ec
valu
shown
tabl
gml
total
alkaloid
l
radiata
nm
form
lycorin
b
determin
concentr
compound
reduc
cell
viabil
control
cell
without
addit
compound
valu
repres
mean
sd
three
independ
experi
unit
cc
valu
shown
tabl
gml
total
alkaloid
l
radiata
nm
form
lycorin
c
select
index
cc
ec
identifi
activ
antivir
substanc
fraction
b
alkaloid
sampl
isol
l
radiata
lcmsm
thermo
finnigan
lcq
deca
xp
appli
compound
analysi
mass
analysi
result
reveal
one
major
peak
mz
suggest
domin
singl
compound
fraction
analysi
found
mass
substanc
match
mass
lycorin
c
h
fig
ali
et
al
chromatogram
lycorin
show
elut
profil
rphplc
main
peak
fraction
b
data
shown
test
commerci
avail
lycorin
nicbp
beij
cpemt
assay
check
inhibit
effect
cpe
induc
viru
result
tabl
show
commerci
lycorin
isol
lycorin
possess
similar
antivir
activ
sarscov
ec
valu
commerci
isol
lycorin
nm
respect
cytotox
assay
also
gener
result
indic
similar
si
valu
two
compound
around
demonstr
lycorin
effect
compon
l
radiata
inhibit
cpe
induc
sarscov
previou
research
provid
good
evid
natur
herb
good
sourc
antivir
compound
glycyrrhizin
activ
compon
licoric
root
report
show
antivir
activ
sarscov
vitro
cinatl
et
al
ec
inhibit
viral
infect
high
gml
plant
extract
eucalyptu
lonicera
japonica
one
pharmacolog
activ
compon
panax
ginseng
also
recent
report
show
activ
sarscov
concentr
wu
et
al
experi
screen
hundr
natur
product
found
four
extract
chines
herb
use
tradit
chines
medicin
exhibit
antisarscov
activ
vero
cellbas
assay
ec
valu
rang
gml
much
better
valu
report
glycyrrhizin
among
four
l
radiata
show
best
potenc
ec
gml
great
si
valu
result
suggest
herb
herb
extract
especi
l
radiata
might
good
candid
antivir
medicin
furthermor
rphplc
purif
l
radiata
extract
lcm
analysi
sampl
combin
cpemt
assay
led
identif
lycorin
potent
antivir
compound
sarscov
ec
valu
nm
viral
inhibit
assay
lower
origin
crude
extract
expect
singl
activ
compon
sever
previou
report
demonstr
lycorin
inhibit
poliomyel
viru
herp
simplex
viru
type
ieven
et
al
renardnozaki
et
al
studi
provid
new
evid
compound
also
antivir
activ
sarscov
altogeth
lycorin
seem
compound
broad
antivir
activ
lycorin
inhibit
sarscov
cpe
inhibit
assay
concentr
well
glycyrrhizin
cc
lycorin
vero
cell
line
test
nm
respect
si
valu
higher
result
suggest
lycorin
properti
meet
need
antivir
drug
howev
mechan
antivir
activ
activ
compound
clear
futur
could
worthwhil
investig
compound
especi
lycorin
interact
express
viral
protein
antigen
also
valuabl
evalu
compound
antivir
assay
viru
yield
reduct
andor
real
time
pcr
viral
rna
replic
conclus
compound
extract
annua
l
radiata
p
lingua
l
aggregata
identifi
show
antivir
activ
sarscov
vero
cellbas
cpemt
screen
structur
activ
studi
determin
lycorin
activ
compon
alkaloid
portion
herbal
plant
l
radiata
result
studi
provid
strong
support
usag
herb
treat
sarscov
infecti
diseas
result
also
demonstr
lycorin
good
candid
develop
new
antivir
medicin
